Piddock L J, Walters R N
Department of Medical Microbiology, Medical School, University of Birmingham, Edgbaston, United Kingdom.
Antimicrob Agents Chemother. 1992 Apr;36(4):819-25. doi: 10.1128/AAC.36.4.819.
The bactericidal effects of five quinolones (at the optimum bactericidal concentration for strain AB1157) on 15 strains of Escherichia coli with mutations in genes for the SOS response or cell division was studied by a viable-count method. The kill rate data were normalized for growth rate and compared to those for the wild type, AB1157. Similar MICs of enoxacin and fleroxacin were obtained for all mutants; however, different mutants had differing susceptibilities to ciprofloxacin, norfloxacin, and nalidixic acid. Killing kinetic studies showed that mutants with constitutive RecA expression (recA730 and spr-55 mutants) survived longer than AB1157 with all quinolones. Mutants deficient in SOS induction, e.g., recA430 and lexA3 mutants, also survived longer, suggesting that induction of the SOS response by quinolones is harmful to wild-type cells. Recombination repair-deficient mutants (recB21, recC22, and recD1009 mutants) were killed more rapidly than AB1157, as were excision repair mutants, except with nalidixic acid. Mutants which were unable to filament (sfiA11 and sfiB114 mutants) survived longer than AB1157 with all agents, but a mutant defective in the Lon protease was killed more quickly. It was concluded that (i) recombination and excision repair were involved in the repair of quinolone-damaged DNA and (ii) continuous induction (in response to exposure to quinolones) of the SOS response, and hence induction of the cell division inhibitor SfiA, causes cell filamentation and thereby contributes to the bactericidal activity of quinolones.
采用活菌计数法研究了5种喹诺酮类药物(在菌株AB1157的最佳杀菌浓度下)对15株在SOS反应或细胞分裂相关基因发生突变的大肠杆菌的杀菌效果。将杀灭率数据按照生长速率进行标准化处理,并与野生型菌株AB1157的数据进行比较。所有突变体对依诺沙星和氟罗沙星的最低抑菌浓度(MIC)相似;然而,不同的突变体对环丙沙星、诺氟沙星和萘啶酸的敏感性不同。杀菌动力学研究表明,组成型RecA表达的突变体(recA730和spr - 55突变体)在所有喹诺酮类药物作用下比AB1157存活时间更长。缺乏SOS诱导的突变体,如recA430和lexA3突变体,也存活更长时间,这表明喹诺酮类药物诱导的SOS反应对野生型细胞有害。重组修复缺陷突变体(recB21、recC22和recD1009突变体)比AB1157被杀灭得更快,切除修复突变体也是如此,但萘啶酸除外。无法形成丝状体的突变体(sfiA11和sfiB114突变体)在所有药物作用下比AB1157存活时间更长,但Lon蛋白酶缺陷的突变体被杀灭得更快。得出的结论是:(i)重组和切除修复参与了喹诺酮类药物损伤DNA的修复;(ii)SOS反应的持续诱导(对喹诺酮类药物暴露的反应),进而诱导细胞分裂抑制剂SfiA,导致细胞丝状体形成,从而有助于喹诺酮类药物的杀菌活性。